Protection against allograft rejection by iron-dithiocarbamate complexes

Radicals for Life: The Various Forms of Nitric Oxide

Volumn , Issue , 2007, Pages 407-422

  Pieper, Galen M ^a  

^a FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41149150469     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452236-8/50019-8     Document Type: Chapter

References (48)

1. Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindale PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, Fowler MB Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996, 93:720-729.
2. Szabolcs MJ, Ravalli S, Minanov O, Sciaacca RR, Michler RE, Cannon PJ Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998, 65:804-812.
3. Worrall NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, Tilton RG, Williamson JR, Ferguson TB Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 1995, 181:63-70.
4. Menon SG, Zhao L, Xu S, Samlowski WE, Shelby J, McGregor J, Barry WH Relative importance of cytotoxic T lymphocytes and nitric oxide-dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts. Transplantation 1998, 66:413-419.
5. Takahishi W, Suzuki J, Izawa A, Takayama K, Yamazaki S, Isobe M Inducible nitric oxide-mediated myocardial apoptosis contributes to graft failure during acute cardiac allograft rejection in mice. Jap. Heart J. 2000, 41:493-506.
6. ω-monomethyl-l-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft survival. Biochim. Biophys. Acta 1994, 1226:225-231.
7. Paul LC, Myllärniemi M, Muzaffar S, Benediktsson H Nitric oxide synthase inhibition if associated with decreased survival of cardiac allografts in the rat. Transplantation 1996, 62:1193-1195.
8. 6- (1-iminoethyl) -l-lysine in acute cardiac transplant rejection. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H525-H534.
9. Szabolcs MJ, Sun J, Ma N, Albala A, Sciacca RR, Philips GB, Parkinson J, Edwards N, Cannon PJ Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection. Circulation 2002, 106:2392-2396.
10. Brandacher G, Zou Y, Obrist P, Steurer W, Werner-Felmayer G, Margreiter R, Werner ER The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac allograft survival. J. Heart Lung Transplant. 2001, 20:747-748.
11. Worrall NK, Misko TP, Sullivan PM, Hui JJ, Ferguson TB Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. Ann. Thorac. Surg. 1996, 62:378-385.
12. Worrall NK, Pyo PT, Botney MD, Misko TP, Sullivan PM, Alexander DG, Lazenby WD, Ferguson TB Inflammatory cell-derived NO modulates cardiac allograft contractile and electrophysiological function. Am. J. Physiol. Heart Circ. Physiol. 1997, 273:H28-H37.
13. Koglin J, Granville DJ, Glysing-Jensen T, Mudgett JS, Carthy CM, McManus BM, Russell ME Attenuated acute cardiac rejection in NOS2-/-recipients correlates with reduced apoptosis. Circulation 1999, 99:836-842.
14. Mannon RB, Roberts K, Ruiz P, Laubach V, Coffman TM Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. J. Heart Lung Transplant. 1999, 18:819-827.
15. +/+ mice. Effects of cellular chimeras on myocardial inflammatio cardiomyocyte damage and apoptosis. Circulation 2001, 103:2514-3520.
16. Casey JJ, Wei XQ, Orr DJ, Gracie JA, Huang FP, Bolton EM, Liew FY, Bradley JA Skin allograft rejection in mice lacking inducible nitric oxide synthase. Transplantation 1997, 64:589-593.
17. Pieper GM, Nilakantan V, Hilton G, Halligan NLN, Felix CC, Kampalath B, Khanna AK, Roza AM, Johnson CP, Adams MB Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1542-H1551.
18. Akizuki E, Akaike T, Okamoto S, Fujii S, Yamaguchi Y, Ogawa M, Maeda H Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats. Proc. Soc. Exp. Biol. Med. 2000, 225:151-159.
19. Pieper GM, Khanna AK, Kampalath BN, Felix CC, Hilton G, Johnson CP, Adams MB, Roza AM Inhibition of nitrosylation, nitration, lymphocyte proliferation and gene expression in acute and delayed cardiac allograft rejection by an orally active dith. J. Cardiovasc. Pharmacol. 2004, 43:522-530.
20. Li H, Samouilov A, Liu X, Zweier JL Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction Evaluation of its role in nitric oxide generation in anoxic tis. J. Biol. Chem. 2001, 276:24482-24489.
21. Li H, Samouilov A, Liu X, Zweier JL Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrate reduction: evaluation of its role in nitrite and nitric oxide generation tissue. Biochemistry 2003, 42:1150-1159.
22. Vanin VF, Liu X, Samouilov A, Stukan RA, Zweier JL Redox properties of iron-dithiocarbamates and their nitrosyl derivatives: implications for their use as traps of nitric oxide in biological systems. Biochim. Biophys. Acta 2000, 1474:365-377.
23. Xia Y, Cardounel AJ, Vanin AF, Zweier JL Electron paramagnetic resonance spectroscopy with N-methyl-D-glucamine dithiocarbamate iron complexes distinguishes nitric oxide and nitroxyl anion in a redox manner: applications in identifying nitrogen monoxide products from nitric oxide synthase. Free Radical Biol. Med. 2000, 29:793-797.
24. Tsuchiya K, Takasugi M, Minakuchi K, Fukuzawa K Sensitive quantitation of nitric oxide by EPR spectroscopy. Free Radical Biol. Med. 1996, 21:733-737.
25. Vanin AF, Poltorakov AP, Mikoyan VD, Kubrina LN, van Faassen E Why iron-dithiocarbamates ensure detection of nitric oxide in cells and tissues. Nitric Oxide 2006, 15:295-311.
26. Joshi MS, Lancaster JR, Liu X, Ferguson TB In situ measurement of nitric oxide production in cardiac isografts and rejecting allografts by an electrochemical method. Nitric Oxide. Biol. Chem. 2001, 5:561-565.
27. Huisman A, Vos I, Van Faassen EE, Joles JA, Gröne H-J, Martasek P, Van Zonneveld A-J, Vanin AF, Rabelink TJ Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J. 2002, 16:1135-1137.
28. Lancaster JR, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem. 1992, 267:10994-10998.
29. Pieper GM, Halligan NLN, Hilton G, Konorev EA, Felix CC, Roza AM, Adams MB, Griffith OW Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 2003, 100:3125-3130.
30. Lai CS, Komarov AM Dithiocarbamate spin traps for in vivo detection of nitric oxide production in mice. Bioradicals Detected by ESR Spectroscopy 1995, 164-171. Birkhäuser Verlag, Basel. H. Hhya-Nishiguchi, L. Packer (Eds.).
31. Pieper GM, Olds C, Hilton G, Lindholm PF, Adams MB, Roza AM Antioxidant treatment inhibits activation of myocardial nuclear factor κ{script}B and inhibits nitrosylation of myocardial heme protein in cardiac transplant reject. Antioxid. Redox Signal 2001, 3:81-88.
32. Pieper GM, Nilakantan V, Zhou X, Khanna AK, Johnson CP, Roza AM, Adams MB, Hilton G, Felix CC Treatment with α-phenyl-N-tert-butynitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in c allografts. J. Pharmacol. Exp. Thera. 2005, 312:774-779.
33. Mankhetkorn S, Abedinzadeh Z, Houee-Levin C Antioxidant action of sodium diethyldithiocarbamate: reaction with hydrogen peroxide and superoxide radical. Free Radical Biol. Med. 1994, 17:517-527.
34. Liu J, Shigenaga MK, Yan LJ, Mori A, Ames BN Antioxidant activity of diethyldithiocarbamate. Free Radical Res. 1996, 24:461-472.
35. Cooper M, Lindholm P, Pieper G, Seibel R, Moore G, Nakanishi A, Dembny K, Komorowski R, Johnson C, Adams M, Roza A Myocardial nuclear factor-êB activity and nitric oxide production in rejecting cardiac allografts. Transplantation 1998, 66:838-844.
36. Pieper GM, Roza AM, Adams MB, Hilton G, Johnson M, Felix CC, Kampalath B, Darkes M, Wanggui Y, Cameron B, Fricker SP A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of a delayed cardiac transplant rejection. J. Cardiovasc. Pharmacol. 2002, 39:441-448.
37. Roza AM, Cooper M, Pieper G, Hilton G, Dembny K, Lai CS, Lindholm P, Komorowski R, Felix C, Johnson C, Adams M NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance. Transplantation 2000, 69:227-231.
38. Hoffman RA, Langrehr JM, Wren SM, Dull KE, Ildstad ST, McCarthy SA, Simmons RL Character-ization of the immunosuppressive effects of nitric oxide in graft vs. host disease. J. Immunol. 1993, 151:1508-1518.
39. MacMicking J, Xie QW, Nathan C Nitric oxide and macrophage function. Ann. Rev. Immunol. 1997, 15:323-350.
40. Hoffman RA, Ford HR Nitric oxide regulation of lymphocyte function. Nitric Oxide and Inflammation 2001, 131-143. Birkhäuser Verlag, Basel, Switzerland. D. Salveminie, T.R. Billiar, Y. Vodovotz (Eds.).
41. Allione A, Bernabei P, Bosticardo M, Ariottie S, Forni G, Novelli F Nitric oxide suppresses human T lymphocyte proliferation through IFNγ-dependent and IFN-ã-independent induction of apoptosis. J. Immunol. 1999, 163:4182-4191.
42. Mahidhara RS, Hoffman RA, Huang S, Wolf-Johnston A, Vodovotz Y, Simmons RL, Billiar TR Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J. Leuk. Biol. 2003, 74:403-411.
43. Van der Veen RC, Dietlin TA, Pen L, Gray JD Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell. Immunol. 1999, 193:194-201.
44. Macphail Se, Gibney CA, Brooks BM, Booth CG, Flanagan BF, Coleman JW Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression. J. Immunol. 2003, 171:4809-4815.
45. Van der Veen RC, Dietlin TA, Hofman FM, Pen L, Segal BH, Holland SM Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide pho oxidase knockout mice. J.Immunol. 2000, 164:5177-5183.
46. Khanna AK, Cairns VR, Becker CG, Hosenpud JD Transforming growth factor (TGF) β and anti-TGFβ antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGFβ in immunosuppression and nephrotoxicity of cyclosporine. Transplantation 1999, 67:882-889.
47. Khanna AK Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. Transplantation 2000, 70:690-694.
48. Khanna AK The immunosuppressive agent tacrolimus induces p21WAF/CIP1WAF1/CIP1 via TGFβ secretion. Biochem. Biophys. Res. Commun. 2003, 302:266-272.